SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-004459
Filing Date
2021-11-15
Accepted
2021-11-15 07:37:07
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K freq-20211115.htm   iXBRL 8-K 56072
2 EX-99.1 freq-ex99_1.htm EX-99.1 193976
3 GRAPHIC img198726637_0.jpg GRAPHIC 4605
  Complete submission text file 0000950170-21-004459.txt   398713

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT freq-20211115_lab.xml EX-101.LAB 18494
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT freq-20211115_pre.xml EX-101.PRE 11508
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT freq-20211115.xsd EX-101.SCH 2489
7 EXTRACTED XBRL INSTANCE DOCUMENT freq-20211115_htm.xml XML 4889
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 211406362
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences